UNITED THERAPEUTICS Corp (UTHR)

Pharmaceutical Preparations

Latest Price

$541.89

TTM P/E

19.42

Normalized P/E

25.04

Div Yield

Book Value

150.78

P/B Ratio

3.59

Valuation metrics

EPS: $27.86

Book value / share: $162.60

Formula: √(22.5 × EPS × BVPS)

Graham Number

$319.25

41% downside

Norm. op. income: $980M (median of 7yr)

Tax rate: 22%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$241.48

55% downside

Base FCF: $748M (median of recent 5yr)

Growth: 13%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$582.10

+7% upside

EPS: $27.86

Target P/E: 25×

Formula: EPS × P/E

P/E Fair Value

$696.50

+29% upside

99.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	5.29M	$2.87B	12.41%	-105.1K	2026-06-30
Avoro Capital Advisors LLC	2.78M	$1.50B	6.51%	-232.2K	2026-06-30
Vanguard Portfolio Management LLC	1.92M	$1.04B	4.50%	-84.3K	2026-06-30
Vanguard Capital Management LLC	1.92M	$1.04B	4.49%	-39.3K	2026-06-30
State Street Corp	1.90M	$1.03B	4.45%	+54.1K	2026-06-30
Renaissance Technologies LLC	1.71M	$925.0M	4.00%	-78.3K	2026-06-30
Wellington Management Group LLP	1.38M	$747.0M	3.23%	-885.2K	2026-06-30
Geode Capital Management, LLC	996.6K	$538.0M	2.34%	-236.4K	2026-06-30
Jupiter Topco LLC	831.1K	$450.0M	1.95%	--	2026-06-30
Caption Management, LLC	754.1K	$408.0M	1.77%	-397.5K	2026-06-30